Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Isopropyl Alcohol Against Chlorhexidine - Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Alejandro E. Macias, Universidad de Guanajuato
ClinicalTrials.gov Identifier:
NCT01361997
First received: May 23, 2011
Last updated: July 13, 2013
Last verified: August 2012
  Purpose

The purpose of this study is to determinate if 70% isopropyl alcohol is not inferior preventing contamination of peripheral hemocultures, compared with 2% chlorhexidine in 70% isopropyl alcohol.


Condition Intervention Phase
Infectious Diseases
Biological: chlorhexidine in isopropyl alcohol
Biological: Isopropyl alcohol
Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Factorial Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Prevention
Official Title: Comparative Study of 70% Isopropyl Alcohol Against 2% Chlorhexidine- 70% Isopropyl Alcohol as Antiseptics to Prevent Hemoculture's Contamination

Resource links provided by NLM:


Further study details as provided by Universidad de Guanajuato:

Primary Outcome Measures:
  • Determine if 70% isopropyl alcohol is not inferior preventing contamination of peripheral hemoculture, compared with 2% chlorhexidine in 70% isopropyl alcohol. [ Time Frame: 120 hours ] [ Designated as safety issue: Yes ]
    It will determine the growth of contaminating germs in hemocultures taken with each antiseptic tested.


Secondary Outcome Measures:
  • Determine the rate of contamination of each antiseptic used. [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    It will determine the rate of contamination at the date of primary completion and the date of study completion. We will consider contaminants the development of Staphylococcus coagulase negative and gram positive bacilli.

  • Description of the most frequent bacterial contaminants. [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]
    It will determine the rate of contamination at the date of primary completion and the date of study completion. We will consider contaminants the development of Staphylococcus coagulase negative and gram positive bacilli.


Enrollment: 1117
Study Start Date: June 2011
Study Completion Date: August 2012
Primary Completion Date: August 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Chlorhexidine in isopropyl alcohol
This arm is composed of 545 hospitalized patients with suspected blood stream infection, to test 2% chlorhexidine gluconate in 70% isopropyl alcohol.
Biological: chlorhexidine in isopropyl alcohol
When a hemoculture is ordered, the laboratory technician will prepare the necessary materials for venipuncture. Previously the technician must take randomly a sealed envelope, where will be writing the antiseptic to be used for antisepsis. The technician will select a site for venipuncture, preferably in the forearm, and will do the antisepsis in the site selected, letting act the substance for 45 seconds. After this procedure, the venipuncture shall be done. The sample will be cultured for 120 hours at 35 +/- 2°C.
Other Names:
  • Chloraprep, Enturia Inc., Texas.
  • BacT/ALERT FA, Biomérieux Inc., North Carolina.
Experimental: Isopropyl alcohol
This arm is composed of 572 hospitalized patients with suspected blood stream infection, to test 70% isopropyl alcohol.
Biological: Isopropyl alcohol
When a hemoculture is ordered, the laboratory technician will prepare the necessary materials for venipuncture. Previously the technician must take randomly a sealed envelope, where will be writing the antiseptic to be used for antisepsis. The technician will select a site for venipuncture, preferably in the forearm, and will do the antisepsis in the site selected, letting act the substance for 45 seconds. After this procedure, the venipuncture shall be done. The sample will be cultured for 120 hours at 35 +/- 2°C.
Other Names:
  • Alcohol Swabs, BD, Madrid.
  • BacT/ALERT FA, Biomérieux Inc., North Carolina.

Detailed Description:

The develop of contaminants in blood cultures is a problem of great impact to health institutions and patients, as they represent a waste of resources, and additionally increases the patient's hospital stay. The principal source of contaminant is the bacteria in the skin flora, so the greatest way to improve the sensibility of this test is to do an optimal skin antisepsis. It has been reported that 2% chlorhexidine gluconate in 70% isopropyl alcohol is superior that other skin disinfectants, and that 70% isopropyl alcohol has a high efficacy reducing the presence of bacteria on the skin, so both antiseptics are good options for skin antisepsis.

  Eligibility

Ages Eligible for Study:   18 Years to 70 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with suspected blood stream infection.
  • Patients allocated in admission, hospitalization and intensive care units.

Exclusion Criteria:

  • Patients with a single peripheral hemoculture.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01361997

Locations
Mexico
University of Guanajuato School of Medicine
Leon, Guanajuato, Mexico, 37000
Sponsors and Collaborators
Universidad de Guanajuato
Investigators
Principal Investigator: Alejandro E. Macias, M. D. University of Guanajuato
  More Information

No publications provided

Responsible Party: Alejandro E. Macias, Full-time professor, Universidad de Guanajuato
ClinicalTrials.gov Identifier: NCT01361997     History of Changes
Other Study ID Numbers: 2011HRAEB001
Study First Received: May 23, 2011
Last Updated: July 13, 2013
Health Authority: Mexico: Secretaria de Salud

Keywords provided by Universidad de Guanajuato:
Antiseptics
Hemoculture contamination
Anti-infecting agents, local

Additional relevant MeSH terms:
Communicable Diseases
Infection
Anti-Infective Agents, Local
Chlorhexidine
Chlorhexidine gluconate
Ethanol
Anti-Infective Agents
Central Nervous System Agents
Central Nervous System Depressants
Dermatologic Agents
Disinfectants
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses

ClinicalTrials.gov processed this record on November 20, 2014